1h Free Analyst Time
The cancer registry software market is forecasted to grow by USD 97.1 million during 2023-2028, accelerating at a CAGR of 12.75% during the forecast period. The report on the cancer registry software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer cases, growing number of cancer registries, and increasing partnerships to improve cancer registries.
The cancer registry software market is segmented as below:
By End-user
- Government and third party
- Pharma biotech and medical device companies
- Hospitals and medical practice
- Private payers
- Research institutes
By Type
- Stand-alone software
- Integrated software
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the cancer registry software market covers the following areas:
- Cancer registry software market sizing
- Cancer registry software market forecast
- Cancer registry software market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global cancer registry software market: CDC, Conduent Inc., Elekta AB, ERS Inc., Inspirata Inc., International Association of Cancer Registries, International Business Machines Corp., McKesson Corp., NeuralFrame Inc., OMH HealthEdge Holdings LLC, Onco Inc., Ordinal Data Inc., Redsson Ltd., Siemens AG, and University of Utah Health.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing clinical research for oncology."
According to the report, one of the major drivers for this market is the growing prevalence of cancer cases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- CDC
- Conduent Inc.
- Elekta AB
- ERS Inc.
- Inspirata Inc.
- International Association of Cancer Registries
- International Business Machines Corp.
- McKesson Corp.
- NeuralFrame Inc.
- OMH HealthEdge Holdings LLC
- Onco Inc.
- Ordinal Data Inc.
- Redsson Ltd.
- Siemens AG
- University of Utah Health
